Release
📈 Stocks
Jiangsu Hengrui Medicine Presents 64 Oncology Research Abstracts at ESMO 2026
(5 days ago)
Jiangsu Hengrui Pharmaceuticals highlights its global oncology R&D capabilities with 64 research abstracts presented at the 2026 ESMO congress in Madrid.